Sipos Éva

Name: Sipos Éva

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2012-2024

2024

Herczeg, M., Demeter, F., Nagy, T., Rusznyák, Á., Hodek, J., Sipos, É., Lekli, I., Fenyvesi, F., Weber, J., Kéki, S., Borbás, A.: Block Synthesis and Step-Growth Polymerization of C-6-Sulfonatomethyl-Containing Sulfated Malto-Oligosaccharides and Their Biological Profiling.
Int. J. Mol. Sci. 25 (1), 1-29, (article identifier: 677), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

Feró, O., Szabóné, V. D., Nagy, É., Karányi, Z., Sipos, É., Engelhardt, J., Török, N., Balogh, I., Vető, B., Liko, I., Fóthi, Á., Szabó, Z., Halmos, G., Vécsei, L., Arányi, T., Székvölgyi, L.: DNA methylome, R-loop and clinical exome profiling of patients with sporadic amyotrophic lateral sclerosis.
Sci Data. 11 (1), 1-12, (article identifier: 123), 2024.

doi DEA Scopus

Journal metrics:

D1 Computer Science Applications

D1 Information Systems

D1 Education

D1 Library and Information Sciences

D1 Statistics and Probability

D1 Statistics, Probability and Uncertainty

Demeter, F., Peleskei, Z., Kútvölgyi, K., Rusznyák, Á., Fenyvesi, F., Kajtár, R., Sipos, É., Lekli, I., Molnár, P., Szöllősi, A. G., Lisztes, E., Tóth, I. B., Borbás, A., Herczeg, M.: Synthesis and Biological Profiling of Seven Heparin and Heparan Sulphate Analogue Trisaccharides.
Biomolecules. 14 (9), 1-24, (article identifier: 1052), 2024.

doi DEA

Journal metrics:

Q1 Biochemistry

Q2 Molecular Biology

Tran, T. B., Sipos, É., Bényei, A., Nagy, S., Lekli, I., Buglyó, P.: Synthesis and Characterization of Novel Co(III)/Ru(II) Heterobimetallic Complexes as Hypoxia-Activated Iron-Sequestering Anticancer Prodrugs.
Molecules. 29 (24), 1-14, (article identifier: 5967), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Analytical Chemistry

Q1 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q2 Molecular Medicine

Q1 Organic Chemistry

Q1 Pharmaceutical Science

Q1 Physical and Theoretical Chemistry

Fésüs, A., Baluku, P., Sipos, É., Somodi, S., Berczi-Kun, E., Lekli, I., Bácskay, I., Benkő, R., Vaskó, A.: The effect of the antibiotic stewardship program (ASP) on community-acquired pneumonia (CAP): a before-after study.
Front. Pharm. 15, 1-12, 2024.

doi DEA

Journal metrics:

Q1 Pharmacology

Q1 Pharmacology (medical)

2023

Fésüs, A., Ábrahám, A., Sipos, É., Szőke, K., Bak, I., Kiss-Szikszai, A., Lekli, I.: Evaluation of the antioxidant effect of kd15 and kd36 newly synthetized molecules.
In: FAMÉ 2023 Mátraháza 7-9 June 2023 : Programme Oral and Poster Abstract / org. Hungarian Society For Experimental And Clinical Pharmacology, Hungarian Physiological Society, Hungarian Society For Microcirculation And Vascular Biology, HUPHAR, [S.l.], 223, 2023.

DEA

2021

Szabó, Z., Dezső, B., Molnár-Fodor, K., Szegedi, K., Flaskó, T., Szabó, E., Oláh, G., Sipos, É., Dobos, N., Gardi, J., Schally, A. V., Halmos, G.: Expression of Luteinizing Hormone-Releasing Hormone (LHRH) and Type-I LHRH Receptor in Transitional Cell Carcinoma Type of Human Bladder Cancer.
Molecules. 26 (5), 1-14, (article identifier: 1253), 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q2 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

2020

Molnár-Fodor, K., Sipos, É., Dobos, N., Nagy, J., Steiber, Z., Méhes, G., Dull, K., Székvölgyi, L., Schally, A. V., Halmos, G.: Correlation between the Expression of Angiogenic Factors and Stem Cell Markers in Human Uveal Melanoma.
Life (Basel). 10 (12), 1-15, 2020.

doi DEA

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Ecology, Evolution, Behavior and Systematics

Q1 Paleontology

Q2 Space and Planetary Science

Molnár-Fodor, K., Dobos, N., Schally, A. V., Steiber, Z., Oláh, G., Sipos, É., Székvölgyi, L., Halmos, G.: The targeted LHRH analog AEZS-108 alters expression of genes related to angiogenesis and development of metastasis in uveal melanoma.
Oncotarget. 11 (2), 175-187, 2020.

doi DEA

Journal metrics:

Q2 Oncology

2019

10.

Halász, L., Karányi, Z., Boros-Oláh, B., Kuik-Rózsa, T., Sipos, É., Nagy, É., Mosolygó, Á., Türk-Mázló, A., Rajnavölgyi, É., Halmos, G., Székvölgyi, L.: Corrigendum: RNA-DNA hybrid (R-loop) immunoprecipitation mapping: an analytical workflow to evaluate inherent biases.
Genome Res. 29 (1), 157-157, 2019.

doi DEA

2018

11.

Sipos, É., Dobos, N., Rózsa, D., Molnár-Fodor, K., Oláh, G., Szabó, Z., Székvölgyi, L., Schally, A. V., Halmos, G.: Characterization of Luteinizing hormone-releasing hormone (LH-RH-I) receptor type I as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines.
OncoTargets Ther. 11, 933-941, 2018.

doi DEA

Journal metrics:

Q2 Oncology

Q2 Pharmacology (medical)

12.

Oláh, G., Dobos, N., Vámosi, G., Szabó, Z., Sipos, É., Molnár-Fodor, K., Harda, K. M., Schally, A. V., Halmos, G.: Experimental therapy of doxorubicin resistant human uveal melanoma with targeted cytotoxic luteinizing hormone-releasing hormone analog (AN-152).
Eur. J. Pharm. Sci. 123, 371-376, 2018.

doi DEA

Journal metrics:

Q1 Pharmaceutical Science

2017

13.

Sipos, É., Dull, K., Treszl, A., Steiber, Z., Méhes, G., Dobos, N., Molnár-Fodor, K., Oláh, G., Székvölgyi, L., Schally, A. V., Halmos, G.: Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.
Oncol. Rep. 37, 1927-1934, 2017.

doi DEA

Journal metrics:

Q3 Cancer Research

Q1 Medicine (miscellaneous)

Q2 Oncology

14.

Halász, L., Karányi, Z., Boros-Oláh, B., Kuik-Rózsa, T., Sipos, É., Nagy, É., Mosolygó, Á., Türk-Mázló, A., Rajnavölgyi, É., Halmos, G., Székvölgyi, L.: RNA-DNA hybrid (R-loop) immunoprecipitation mapping: an analytical workflow to evaluate inherent biases.
Genome Res. 27, 1063-1073, 2017.

doi DEA

Journal metrics:

D1 Genetics

D1 Genetics (clinical)

2015

15.

Szabó, I., Bősze, S., Orbán, E., Sipos, É., Halmos, G., Kovács, M., Mező, G.: Comparative in vitro biological evaluation of daunorubicin containing GnRH-I and GnRH-II conjugates developed for tumor targeting.
J. Pept. Sci. 21 (5), 426-435, 2015.

doi DEA

Journal metrics:

Q3 Biochemistry

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Biology

Q3 Molecular Medicine

Q2 Organic Chemistry

Q2 Pharmacology

Q3 Structural Biology

2014

16.

Steiber, Z., Sipos, É., Dull, K., Halmos, G., Méhes, G., Treszl, A.: Aneuploidy of chromosome 3 and 4 in human uveal melanomas detected by fluorescence in situ hybridization.
Invest. Ophthalmol. Vis. Sci. 55, 6444, 2014.

DEA

2012

17.

Hegedűs, R., Manea, M., Orbán, E., Szabó, I., Kiss, É., Sipos, É., Halmos, G., Mező, G.: Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin-GnRH-III bioconjugates.
Eur. J. Med. Chem. 56, 155-165, 2012.

doi DEA

Journal metrics:

Q1 Drug Discovery

Q1 Medicine (miscellaneous)

Q1 Organic Chemistry

Q1 Pharmacology